New Liver-Targeted chemo aims to slash Cancer's return after surgery
NCT ID NCT07284394
Summary
This study is for people with colorectal cancer that has spread to the liver and who are at high risk of the cancer returning after surgery. Researchers are testing if delivering a chemotherapy drug (oxaliplatin) directly into the liver's blood supply is more effective at preventing recurrence than giving it through a standard IV. The goal is to see if this targeted approach helps patients stay cancer-free for longer after their initial surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.